// App-Quantinova.ai

2393 : Risk of Thromboembolism with Janus Kinase Inhibitors: A Systematic Review and Meta-Analysis of Randomized Placebo Controlled Trials

Researchers

Presenter

  • Irbaz Bin Riaz

Principal Investigators

  • Maryam Sadiq

  • Muhammad Salick

  • Yahya Nomaan

  • Nusrum Iqbal

  • Sandipan Bhattacharjee

  • Lary Prokop

  • C. Kent Kwoh

Medical Centers

  • University of Arizona College of Medicine Tuscon, Tuscon, AZ

  • Mayo Hospital Rochester, Rochester, MN

  • Nishtar Medical College, University of Health Sciences, Lahore, Albany, NY

  • Albany Medical Center, Albany, NY

  • Phoenix Children's Hospital, Phoenix, AZ

  • St Joseph's Hospital, Tucson AZ, Tucson, AZ

  • University of Arizona, Tucson, AZ

  • Mayo Clinic, Rochester, MN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Janus kinase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Controlled

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved